Related Experiment Video
Updated: Sep 4, 2025

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Chronic Subdural Hematoma, Caused by Disseminated Intravascular Coagulation and/or Anticoagulation Therapy, after
Yu Nomura1, Masato Naraoka1, Nozomi Fujiwara1
1Department of Neurosurgery, Hirosaki University School of Medicine, Hirosaki, Aomori, Japan.
Insights
Chronic subdural hematoma (CSDH) can occur after COVID-19 infection, even without head trauma. This case highlights the risk of CSDH due to post-COVID-19 coagulopathy, particularly in infratentorial regions.
Area of Science:
- Neurology
- Infectious Diseases
- Hematology
Background:
- Chronic subdural hematoma (CSDH) typically affects elderly individuals and is usually supratentorial.
- COVID-19 infection has been linked to various neurological and hematological complications.
- Disseminated intravascular coagulation (DIC) is a serious condition that can arise secondary to infections.
Observation:
- A patient presented with both unilateral supratentorial and bilateral infratentorial CSDH.
- The patient had a history of COVID-19 infection and disseminated intravascular coagulation two months prior.
- No history of head trauma was reported preceding the CSDH onset.
Findings:
- This case demonstrates an unusual presentation of CSDH, involving both supratentorial and infratentorial compartments.
- The development of CSDH occurred in the absence of traumatic brain injury, suggesting an alternative etiology.
- Coagulopathy secondary to a prior COVID-19 infection and DIC is implicated as a potential cause.
Implications:
- Clinicians should consider CSDH as a potential delayed complication following COVID-19 infection, especially in patients with coagulopathy.
- Awareness of non-traumatic CSDH is crucial, particularly in the context of recent viral infections.
- Further research is warranted to elucidate the mechanisms linking COVID-19-associated coagulopathy to CSDH development.
Abstract:
Chronic subdural hematoma (CSDH) typically develops in the supratentorial region in elderly patients. We treated a case of unilateral supratentorial and bilateral infratentorial CSDH, whereby the patient had a coronavirus disease 2019 (COVID-19) infection combined with disseminated intravascular coagulation 2 months earlier. The patient had not experienced any head trauma before the onset of the CSDH. The postoperative course was uneventful, and the patient experienced no neurological deficit. We propose that we should be aware not only of acute ischemic or hemorrhagic diseases after COVID-19 infection but also of chronic subdural hematoma caused by coagulopathy after a COVID-19 infection.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

